Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
- Conditions
- CholangiocarcinomaDrainageSurgery
- Interventions
- Procedure: Preoperative biliary drainage
- Registration Number
- NCT00797121
- Lead Sponsor
- Sun Yat-sen University
- Brief Summary
This study is to investigate whether preoperative biliary drainage can reduce the postoperative morbidity in patients with hilar cholangiocarcinoma.
- Detailed Description
Preoperative biliary drainage(PBD) or not, is a Hot Spot issue in the management of Hilar cholangiocarcinoma. Surgeons from Japan tend to perform PTBD(Percutaneous Transhepatic Biliary Drainage) before a definite operation until the total bilirubin(TB) lower than 85μmol/L. For some patients needed to perform extended curative resection, PVE(Portal Vein Embolization) is performed and thus the duration of PBD may be around six weeks and the final TB is lower than 34μmol/L. Some tend to perform a definite curative operation in a short time after diagnosis. There is no RCT research on the effect of PBD for the resectable Hilar Cholangiocarcinoma patients to date.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 82
- Patients newly diagnosed
- Resectable patients after imaging assessment and evaluation of general condition of the patient
- TB>85μmol/L
- WBC account more than 1.5×109/L, PLT account more than 100×109/L and HB account more than 100g/L
- No serious disease in heart, lung and kidney
- Written informed consent
- Unresectable patients.
- Patients have received biliary drainage procedure such as PTBD before admission
- Complicated with chronic hepatitis
- Myocardia infarction record within six months
- Women in pregnancy
- Serious disease in heart, lung or kidney
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Preoperative biliary drainage Preoperative biliary drainage -
- Primary Outcome Measures
Name Time Method Incidence of postoperative complication 30 days after operation
- Secondary Outcome Measures
Name Time Method Postoperative mortality 30 days after operation Overall survival, OS May, 2013 Disease free survival, DFS May, 2013
Trial Locations
- Locations (1)
Department of Hepatobiliary, the first affiliated hospital, Sun Yat-sen University
🇨🇳Guangzhou, Guangdong, China